NKX2-5
Homeobox protein Nkx-2.5
Also known as: CSX, CSX1, NKX2.5, NKX25_HUMAN, NKX2E, NKX4-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P52952
- Gene
- NKX2-5
- Ensembl
- ENSG00000183072
- Chromosome
- 5
- Canonical length
- 324 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a homeobox-containing transcription factor. This transcription factor functions in heart formation and development. Mutations in this gene cause atrial septal defect with atrioventricular conduction defect, and also tetralogy of Fallot, which are both heart malformation diseases. Mutations in this gene can also cause congenital hypothyroidism non-goitrous type 5, a non-autoimmune condition. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
324 residues, UniProt reviewed canonical sequence.
>P52952|NKX2-5
1 MFPSPALTPT PFSVKDILNL EQQQRSLAAA GELSARLEAT LAPSSCMLAA FKPEAYAGPE
61 AAAPGLPELR AELGRAPSPA KCASAFPAAP AFYPRAYSDP DPAKDPRAEK KELCALQKAV
121 ELEKTEADNA ERPRARRRRK PRVLFSQAQV YELERRFKQQ RYLSAPERDQ LASVLKLTST
181 QVKIWFQNRR YKCKRQRQDQ TLELVGLPPP PPPPARRIAV PVLVRDGKPC LGDSAPYAPA
241 YGVGLNPYGY NAYPAYPGYG GAACSPGYSC TAAYPAGPSP AQPATAAANN NFVNFGVGDL
301 NAVQSPGIPQ SNSGVSTLHG IRAWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NKX2-5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 234 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 234 nTPM
- spleen: 37 nTPM
- tongue: 12 nTPM
- blood vessel: 1.4 nTPM
- adipose tissue: 0.7 nTPM
- salivary gland: 0.6 nTPM
Single-cell type
- cardiomyocytes: 20 nCPM
- epicardial cells: 4.5 nCPM
- breast myoepithelial cells: 2.6 nCPM
- undifferentiated spermatogonia: 1.7 nCPM
- myosatellite cells: 1.2 nCPM
- differentiating spermatogonia: 1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.3 nTPM
- midbrain: 0.3 nTPM
- amygdala: 0.2 nTPM
- basal ganglia: 0.2 nTPM
- cerebellum: 0.2 nTPM
- hippocampal formation: 0.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NKX2-5.
Disease | AllUniProt
Conditions NKX2-5 is implicated in, by any mechanism.
- Atrial septal defect 7, with or without atrioventricular conduction defects (ASD7) MIM:108900
- Tetralogy of Fallot (TOF) MIM:187500
- Conotruncal heart malformations (CTHM) MIM:217095
- Hypothyroidism, congenital, non-goitrous, 5 (CHNG5) MIM:225250
- Ventricular septal defect 3 (VSD3) MIM:614432
- Hypoplastic left heart syndrome 2 (HLHS2) MIM:614435
Disease | GeneticClinVar
128 pathogenic / likely-pathogenic of 818 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.95
- gnomAD missense Z
- 0.2
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
OntologyGO
Biological processes
- adult heart development
- aortic valve morphogenesis
- apoptotic process involved in heart morphogenesis
- atrial cardiac muscle cell development
- atrial cardiac muscle tissue development
- atrial septum morphogenesis
- atrioventricular node cell development
- atrioventricular node cell fate commitment
- atrioventricular node development
- bundle of His development
- cardiac conduction system development
- cardiac muscle cell development
- cardiac muscle cell proliferation
- cardiac muscle contraction
- cardiac muscle tissue morphogenesis
- cardiac septum morphogenesis
- cardiac ventricle formation
- cell differentiation
- embryonic heart tube development
- embryonic heart tube left/right pattern formation
- epithelial cell apoptotic process
- epithelial cell differentiation
- epithelial cell proliferation
- heart development
- heart looping
- heart morphogenesis
- heart trabecula formation
- hemopoiesis
- negative regulation of apoptotic process
- negative regulation of canonical Wnt signaling pathway
- negative regulation of cardiac muscle cell apoptotic process
- negative regulation of DNA-templated transcription
- negative regulation of epithelial cell apoptotic process
- negative regulation of myotube differentiation
- negative regulation of transcription by RNA polymerase II
- outflow tract septum morphogenesis
- pharyngeal system development
- positive regulation of cardioblast differentiation
- positive regulation of cell population proliferation
- positive regulation of DNA-templated transcription
- positive regulation of epithelial cell proliferation
- positive regulation of gene expression
- positive regulation of heart contraction
- positive regulation of neuron differentiation
- positive regulation of sodium ion transport
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription initiation by RNA polymerase II
- proepicardium development
- pulmonary myocardium development
- regulation of cardiac conduction
- regulation of cardiac muscle cell proliferation
- regulation of cardiac muscle contraction
- regulation of DNA-templated transcription
- regulation of transcription by RNA polymerase II
- right ventricular cardiac muscle tissue morphogenesis
- spleen development
- thyroid gland development
- transcription by RNA polymerase II
- vasculogenesis
- ventricular cardiac muscle cell development
- ventricular cardiac myofibril assembly
- ventricular septum morphogenesis
- ventricular trabecula myocardium morphogenesis
- Purkinje myocyte differentiation
- septum secundum development
Molecular functions
- chromatin binding
- DNA binding
- DNA-binding transcription activator activity
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- protein homodimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- transcription cis-regulatory region binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NKX2-5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NKX2-5 as an antibody target. Whether an autoantibody or antibody against NKX2-5 could matter depends on whether native NKX2-5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NKX2-5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- Mutations in this gene can also cause congenital hypothyroidism non-goitrous type 5, a non-autoimmune condition.
Loading the interactive Seroatlas protein explorer...